$1.27
+0.02 (+1.60%)
Open$1.27
Previous Close$1.25
Day High$1.27
Day Low$1.23
52W High$1.27
52W Low$0.56
Volume—
Avg Volume465.5K
Market Cap16.26M
P/E Ratio—
EPS$-1.11
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+3,408.7% upside
Current
$1.27
$1.27
Target
$44.56
$44.56
$28.75
$44.56 avg
$50.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 53.33M | 47.07M | 1.67M |
| Net Income | -13,473,889 | -10,702,056 | 470.0K |
| Profit Margin | -25.3% | -24.0% | 28.1% |
| EBITDA | -14,336,332 | -12,019,694 | 856.8K |
| Free Cash Flow | — | — | 585.2K |
| Rev Growth | +13.3% | +13.3% | +24.3% |
| Debt/Equity | 0.44 | 0.44 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |